BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36052238)

  • 41. The prognostic impact of tumour location and first-line chemotherapy regimen in locally advanced pancreatic cancer.
    Takeda T; Sasaki T; Mie T; Furukawa T; Yamada Y; Kasuga A; Matsuyama M; Ozaka M; Sasahira N
    Jpn J Clin Oncol; 2021 Apr; 51(5):728-736. PubMed ID: 33611490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination therapy with gemcitabine and nab-paclitaxel for locally advanced unresectable pancreatic cancer.
    Saito T; Ishido K; Kudo D; Kimura N; Wakiya T; Nakayama Y; Hakamada K
    Mol Clin Oncol; 2017 Jun; 6(6):963-967. PubMed ID: 28588798
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The efficacy and safety of albumin-bound paclitaxel plus carboplatin as neoadjuvant therapy for potentially resectable lung squamous cell carcinoma: a real-world retrospective cohort study.
    Jiang W; Zhou Y; Zeng L; Xiong Y; Liu L; Zhou C; Yang H; Guo H; Minervini F; Bongiolatti S; Yang N; Zhang Y; Tao M
    Transl Lung Cancer Res; 2022 Apr; 11(4):647-655. PubMed ID: 35529791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Progress in conversion therapy for originally unresectable gastric cancer].
    Chen X; Lin Z; Chen Y; Luo J; Zhu Y; Liu H; Li G; Yu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1191-1195. PubMed ID: 30370519
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Locally advanced gallbladder cancer treated with effective chemotherapy and subsequent curative resection: a case report.
    Inoue M; Hakoda K; Sawada H; Hotta R; Ohmori I; Miyamoto K; Toyota K; Sadamoto S; Takahashi T
    J Med Case Rep; 2022 Jan; 16(1):30. PubMed ID: 35039070
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Curative surgical resection for initially unresectable metastatic gallbladder cancer following neoadjuvant chemotherapy: Case report and review of literature.
    Al Jaber F; Almaher E; Al-Ibrahim R; AlQahtani M
    Int J Surg Case Rep; 2022 Nov; 100():107694. PubMed ID: 36242892
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multimodality management of gallbladder cancer can lead to a better outcome: Experience from a tertiary care oncology centre in North India.
    Goel S; Aggarwal A; Iqbal A; Talwar V; Mitra S; Singh S
    World J Gastroenterol; 2021 Dec; 27(45):7813-7830. PubMed ID: 34963744
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A case of successful conversion surgery for locally advanced pancreatic cancer with synchronous triple cancer of the lung and esophagus: a case report.
    Mita J; Iguchi T; Iseda N; Takada K; Hirose K; Miura N; Honboh T; Emi Y; Akashi T; Kato S; Sadanaga N; Matsuura H
    Surg Case Rep; 2022 Jan; 8(1):19. PubMed ID: 35067787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. S-1, Oxaliplatin, Nab-paclitaxel and Itraconazole for Conversion Surgery for Advanced or Recurrent Gastric Cancer.
    Sawasaki M; Tsubamoto H; Nakamoto Y; Kakuno A; Sonoda T
    Anticancer Res; 2020 Feb; 40(2):991-997. PubMed ID: 32014944
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of Nab-Paclitaxel Plus Gemcitabine Followed by Hypofractionated Tomotherapy With Simultaneous Integrated Boost in Patients With Locally Advanced Pancreatic Cancer.
    Shi Z; Yang J; Kong W; Qiu X; Lu C; Liu J; Liu B; Du J
    Front Oncol; 2022; 12():782730. PubMed ID: 35299738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Examination of the characteristics of long-term survivors among patients with gallbladder cancer with liver metastasis who underwent surgical treatment: a retrospective multicenter study (ACRoS1406).
    Higuchi R; Ono H; Matsuyama R; Takemura Y; Kobayashi S; Otsubo T; Abe Y; Endo I; Tanabe M; Yamamoto M;
    BMC Gastroenterol; 2022 Mar; 22(1):152. PubMed ID: 35346072
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination of portal vein embolization and neoadjuvant chemotherapy for locally advanced gallbladder cancer requiring extended hepatectomy - A novel approach.
    Singh S; Goel S; Aggarwal A; Iqbal A; Hazarika D; Talwar V
    Indian J Gastroenterol; 2021 Dec; 40(6):580-589. PubMed ID: 34966973
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report.
    Matsumoto R; Arigami T; Matsushita D; Okubo K; Tanaka T; Yanagita S; Sasaki K; Noda M; Kita Y; Mori S; Kurahara H; Ohtsuka T
    World J Surg Oncol; 2020 Jul; 18(1):179. PubMed ID: 32693806
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase II trial of weekly nab-paclitaxel and carboplatin treatment with or without trastuzumab as nonanthracycline neoadjuvant chemotherapy for locally advanced breast cancer.
    Huang L; Chen S; Yao L; Liu G; Wu J; Shao Z
    Int J Nanomedicine; 2015; 10():1969-75. PubMed ID: 25792830
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy-the P-SELECT trial (WJOG10617G)-a randomised phase II trial by the West Japan Oncology Group.
    Hirata K; Hamamoto Y; Ando M; Imamura CK; Yoshimura K; Yamazaki K; Hironaka S; Muro K
    BMC Cancer; 2020 Jun; 20(1):548. PubMed ID: 32532230
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Attenuated regimen of biweekly gemcitabine/nab-paclitaxel in patients aged 65 years or older with advanced pancreatic cancer.
    Rehman H; Chi J; Hakim N; Goyal SP; Olazagasti C; Jose J; Moriarty L; Saif MW
    Therap Adv Gastroenterol; 2020; 13():1756284820974912. PubMed ID: 33281939
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer - A systematic review.
    Hakeem AR; Papoulas M; Menon KV
    Eur J Surg Oncol; 2019 Feb; 45(2):83-91. PubMed ID: 30287098
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Resection of Locally Advanced Pancreatic Neoplasms after Neoadjuvant Chemotherapy with Nab-Paclitaxel and Gemcitabine following FOLFIRINOX Failure.
    Hahn S; Ayav A; Lopez A
    Case Rep Gastroenterol; 2017; 11(2):422-427. PubMed ID: 29033758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phase II study of neoadjuvant therapy with nab-paclitaxel and cisplatin followed by surgery in patients with locally advanced esophageal squamous cell carcinoma.
    Fan Y; Jiang Y; Zhou X; Chen Q; Huang Z; Xu Y; Gong L; Yu H; Yang H; Liu J; Lei T; Zhao Q; Mao W
    Oncotarget; 2016 Aug; 7(31):50624-50634. PubMed ID: 27244882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer.
    Fukuchi M; Ishiguro T; Ogata K; Suzuki O; Kumagai Y; Ishibashi K; Ishida H; Kuwano H; Mochiki E
    Ann Surg Oncol; 2015 Oct; 22(11):3618-24. PubMed ID: 25663597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.